CompoAtlas

Muro 128 5% Solution

Natural health product licensed in Canada

Licence holder
Bausch & Lomb Inc.
NPN or DIN-HM
00750824
Status
Active licence
Licence date
27 July 2009
Revision date
23 December 2024
Form
Solution
Route of administration
Ophthalmique
Application type
DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Chlorure de sodium

Source : Chlorure de sodium

50 mg/ml
Chlorure de sodium

Source : Chlorure de sodium

5 % (p/v)

Non-medicinal ingredients

propylèneglycol, (p)-hydroxybenzoate de propyle, Eau purifiée, acide hydrochlorique, Borate de sodium, Hydroxyde de sodium, acide borique, Hypromellose, Parahydroxybenzoate de méthyle

PopulationAgeQuantity per servingFrequency
Sous-population S/ONot specifiedminimum: 1 Goutte(s) ; maximum: 2 Goutte(s)minimum: 3 hours ; maximum: 4 hours

Uses authorised in Canada

Text supplied in English because no French text is available.

For the temporary relief of corneal edema.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 00750824

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line